78 related articles for article (PubMed ID: 1659480)
1. [The screening model for early diagnosis of colorectal cancer in general population].
Zheng S
Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):381-4, 28. PubMed ID: 1659480
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
Yu H
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
[TBL] [Abstract][Full Text] [Related]
4. Results of screening for colorectal cancer.
Crespi M; Casale V; Grassi A; Caperle M; Casale G; Conti E
Endoscopy; 1981 Sep; 13(5):203-6. PubMed ID: 7274170
[TBL] [Abstract][Full Text] [Related]
5. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
[TBL] [Abstract][Full Text] [Related]
6. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
8. [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].
Chen K
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):37-40. PubMed ID: 8334938
[TBL] [Abstract][Full Text] [Related]
9. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer screening: new opportunities.
Levin TR
Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
[TBL] [Abstract][Full Text] [Related]
12. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
Fric P; Zavoral M; Dvoráková H; Zoubek V; Roth Z
Hepatogastroenterology; 1994 Oct; 41(5):413-6. PubMed ID: 7851847
[TBL] [Abstract][Full Text] [Related]
13. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
[TBL] [Abstract][Full Text] [Related]
15. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
[TBL] [Abstract][Full Text] [Related]
16. Screening for colon malignancy with colonoscopy.
Lieberman DA; Smith FW
Am J Gastroenterol; 1991 Aug; 86(8):946-51. PubMed ID: 1858758
[TBL] [Abstract][Full Text] [Related]
17. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
18. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening in average risk individuals.
Huang CS; Lal SK; Farraye FA
Cancer Causes Control; 2005 Mar; 16(2):171-88. PubMed ID: 15868457
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
